Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROKA

(ROKA) (ROKA) Stock Price, News & Analysis

(ROKA) logo

About (ROKA) Stock (NASDAQ:ROKA)

Advanced Chart

Key Stats

Today's Range
$0.65
$0.69
50-Day Range
N/A
52-Week Range
$0.60
$6.20
Volume
242,292 shs
Average Volume
371,374 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Receive ROKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter.

ROKA Stock News Headlines

"I'm risking my reputation on this"
Crypto book predicted the last bull run (get it FREE now) This newly updated edition contains everything we've learned from interviewing the biggest names in crypto on our Crypto 101 podcast, which has over 17 million downloads and 600+ episodes. "Crypto Revolution" isn't just another book – it's your roadmap to potentially life-changing wealth in the current crypto bull run
See More Headlines

ROKA Stock Analysis - Frequently Asked Questions

(ROKA) (NASDAQ:ROKA) posted its quarterly earnings results on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company earned $2.04 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROKA) investors own include Credit Suisse High Yield Bond Fund (DHY), Western Asset High Income Fund II (HIX), Pimco Corporate & Income Opportunity Fund (PTY), ASML (ASML), Corbus Pharmaceuticals (CRBP), Stag Industrial (STAG) and Twitter (TWTR).

Company Calendar

Last Earnings
5/11/2017
Today
6/20/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ROKA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:ROKA) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners